Expect FTC nod for $900 million Sandoz deal before December: Aurobindo Pharma

Expect FTC nod for $900 million Sandoz deal before December: Aurobindo Pharma The company had announced the acquisition of Sandoz#39;s dermatology and formulations business in September last year, making it the largest outbound deal by an Indian pharma company.

No comments:

Post a Comment